AI World Shaken by Monumental Investment!
Anthropic Hits a Jaw-Dropping $380 Billion Valuation After $30 Billion Series G Funding!
Anthropic, creators of the stunning Claude AI models, just raised a staggering $30 billion in their Series G funding, achieving a valuation of $380 billion. This funding round, led by giants like GIC and Coatue and featuring notable names like Microsoft and Nvidia, sets the stage for even more groundbreaking AI research and product development. From zero to a $14 billion revenue run‑rate in only three years, Anthropic is outpacing traditional software companies while trying to stay ahead of competitors like OpenAI.
Introduction to Anthropic's Latest Funding Achievement
Overview of Series G Funding Round
Key Investors and Leadership in the Funding
Anthropic's Revenue Growth and Future Trajectory
Comparison with Competitors in the AI Industry
Utilization of the Funding for AI Advancements
Challenges and Unprofitability Concerns
Impact on AI Investment Landscape
Public Reactions and Market Analysis
Future Economic, Social, and Political Implications
Related News
Apr 24, 2026
Singapore Tops Global Per Capita Usage of Anthropic’s Claude AI
Singapore leads the world in per capita adoption of Anthropic's Claude AI model, reflecting a rapid integration of AI in business. GIC's senior VP Dominic Soon highlights the massive benefits of responsible AI deployment at a recent GIC-Anthropic event. With a US$1.5 billion investment in Anthropic, GIC underscores its commitment to AI development.
Apr 24, 2026
DeepSeek's Open-Source A.I. Surge: Game Changer in Global Competition
DeepSeek's release of its open-source V4 model propels its position in the A.I. race, challenging American giants with cost-efficiency and openness. For global builders, this marks a new era of accessible, powerful tools for software development.
Apr 24, 2026
White House Hits Back at China's Alleged AI Tech Theft
A White House memo has accused Chinese firms of large-scale AI technology theft. Michael Kratsios warns of systematic tactics undermining US R&D. No specific punitive measures detailed yet.